Dietmar Hopp (Photo by: Uwe Anspach/picture-alliance/dpa/AP Images)
February 17, 2022 10:15 AM EST
Financing

Biotech bil­lion­aire Di­et­mar Hopp digs deep­er to back one of the drug de­vel­op­ers in his port­fo­lio

John Carroll

Editor & Founder

Biotech bil­lion­aire Di­et­mar Hopp is open­ing up the cash vault to help out one of his biotech star­tups.

Op­er­at­ing through dievi­ni Hopp BioTech hold­ing, Hopp …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

Maze's ALS spin­out Trace Neu­ro­science rais­es $101M for ALS and neu­ro work

Up­dat­ed: As­traZeneca, Dai­ichi Sankyo re­place lung can­cer fil­ing for En­her­tu suc­ces­sor

Roche teams with Flare Ther­a­peu­tics on tran­scrip­tion fac­tors

Neu­ro­gene's stock falls in post-mar­ket trad­ing af­ter ear­ly da­ta in Rett syn­drome

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times